In a recent episode of the SlateCast, Paul Kohlhaas, the founder of BIO Protocol, joined CryptoSlate CEO Nate Whitehill and Senior Editor Liam “Akiba” Wright to discuss the future of biotechnology through decentralized science (DeSci). Kohlhaas explained BIO Protocol’s vision for revolutionizing biotech funding and research by utilizing decentralized, open-source methods.
Biotechnology as the Substrate for Life
BIO XYZ represents more than a typical biotech initiative. As Kohlhaas explained,
“BIO XYZ stands for a movement to not be afraid of biotechnology, to like embrace it, and that it should be much more open source, back in the hands of the people.”
The concept draws from “bio-accelerationism,” echoing the AI acceleration movement in the tech world. Kohlhaas argues that biotechnology should be considered a new “substrate for life,” akin to how artificial intelligence became a new substrate for intelligence.
Kohlhaas elaborated on the fear surrounding biotechnology and genetic engineering, drawing parallels with the early fears surrounding AI.
“People are afraid of genetic engineering and new biotechnological advances. However, just as AI has seen a movement to decentralize it, we believe biotechnology should be back in the hands of the people.”
Empowering Patients and Scientists with DAOs
BIO Protocol’s core innovation is decentralizing biotech research by connecting scientists, patients, and investors through decentralized autonomous organizations (DAOs). These DAOs allow communities to fund research that addresses specific medical challenges directly. Kohlhaas highlighted VitaDAO as a successful example, stating,
“VitaDAO funded research into autophagy activators—substances that help healthy cells eliminate old cells—leading to novel drug developments.”
In this decentralized model, patients can have a more significant role, providing funds and valuable insights. “Patients often know what’s best for them,” Kohlhaas remarked, emphasizing the importance of involving patient groups in early-stage biotech research.
